167 related articles for article (PubMed ID: 32890893)
1. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
3. Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
Lopes M; Carvalho B; Vaz R; Linhares P
J Neurooncol; 2018 Jan; 136(1):173-180. PubMed ID: 29076002
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival.
Wang PF; Meng Z; Song HW; Yao K; Duan ZJ; Yu CJ; Li SW; Yan CX
Front Pharmacol; 2018; 9():886. PubMed ID: 30154718
[No Abstract] [Full Text] [Related]
6. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme.
Mermut O; Inanc B
Turk Neurosurg; 2020; 30(5):658-665. PubMed ID: 32530473
[TBL] [Abstract][Full Text] [Related]
7. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
Shi X; Li H; Xu Y; Nyalali AMK; Li F
Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
[TBL] [Abstract][Full Text] [Related]
10. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.
Wang PF; Song HW; Cai HQ; Kong LW; Yao K; Jiang T; Li SW; Yan CX
Oncotarget; 2017 Jul; 8(30):50117-50123. PubMed ID: 28223536
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
Mercier J; Voutsadakis IA
J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
Wang DP; Kang K; Lin Q; Hai J
Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
[TBL] [Abstract][Full Text] [Related]
15. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma.
Madhugiri VS; Moiyadi AV; Shetty P; Gupta T; Epari S; Jalali R; Subeikshanan V; Dutt A; Sasidharan GM; Roopesh Kumar VR; Shankar Ganesh CV; Ramesh AS; Sathia Prabhu A
World Neurosurg; 2021 May; 149():e758-e765. PubMed ID: 33540096
[TBL] [Abstract][Full Text] [Related]
18. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of postoperatif controlling nutritional status (CONUT) score in glioblastoma multiforme.
Yılmaz H; Niğdelioğlu B; Oktay E; Meydan N
J Clin Neurosci; 2021 Apr; 86():260-266. PubMed ID: 33775339
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
Mitsuya K; Nakasu Y; Kurakane T; Hayashi N; Harada H; Nozaki K
J Neurosurg; 2017 Aug; 127(2):433-437. PubMed ID: 27911233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]